Objectives
- Understand metabolic-inflammatory regulation as a central axis of ageing
- Recognise early signals of inflammageing and metabolic drift
- Interpret muscle mass and visceral fat as regulatory markers
- Apply phenotype pattern recognition to clinical practice
Pre-requisites
Completion of the Certificate in Anti-Ageing & Longevity Medicine or equivalent foundational training in longevity medicine principles.
Learners should have a working understanding of biological ageing mechanisms and systems-based clinical thinking.
Who Is It For
This module is designed for healthcare professionals seeking to expand their understanding of ageing medicine:
Development Outcomes
Course Aims & Objectives:
- Maintenance and development of knowledge and skill within your field of practice
- Expand assessment options for patients with metabolic and inflammatory ageing patterns
- Integrate sarcopenia and inflammageing assessment into existing clinical frameworks
In systems-based anti-ageing medicine, metabolic–inflammatory ageing is understood as a regulatory drift, not simply as diabetes, obesity, or inflammatory disease.
1. The Metabolic–Inflammatory Regulatory System
This system integrates:
- Insulin and glucose regulation
- Skeletal muscle as a metabolic and endocrine organ
- Adipose tissue signalling and visceral fat biology
- Low-grade inflammatory signalling (cytokines)
- Interaction with stress, sleep, and vascular regulation
Together, these mechanisms determine energy availability, repair capacity, and long-term physiological reserve.
2. How Metabolic–Inflammatory Regulation Changes With Age
With ageing:
- Insulin sensitivity gradually declines
- Skeletal muscle mass and function reduce (sarcopenia)
- Visceral fat signalling increases
- Baseline inflammatory tone rises ("inflammageing")
- Recovery from physical and cognitive stress slows
This pattern represents loss of metabolic flexibility, not simply disease onset.
3. Early Clinical Signals of Metabolic–Inflammatory Ageing
Before formal diagnoses of metabolic syndrome or diabetes, clinicians may observe:
- Persistent fatigue or low energy
- Weight redistribution rather than weight gain alone
- Brain fog or reduced cognitive clarity
- Poor recovery from exercise or illness
- Increased stiffness or reduced physical tolerance
These are interpreted as early metabolic–inflammatory signals, not isolated symptoms.
4. Phenotype Connections
Certain phenotype patterns are commonly associated with metabolic–inflammatory strain:
5. Systems Interpretation (Not Treatment)
Learners are trained to ask:
→Is this metabolic or inflammatory-dominant?
→Is this reversible with lifestyle change or structurally embedded?
→Are overlapping stress, circadian, or vascular signals present?
6. Boundaries & Professional Scope
This topic does not teach:
- ✗Diabetes management protocols
- ✗Weight loss interventions
- ✗Anti-inflammatory prescribing
It focuses on understanding metabolic–inflammatory ageing as a regulatory process.
How This Topic Fits Within the Diploma
Metabolic–inflammatory regulation links closely with: